Geode Capital Management, LLC Fulgent Genetics, Inc. Transaction History

Geode Capital Management, LLC

$1.21 Trillion
Q3 2024

A detailed history of Geode Capital Management, LLC transactions in Fulgent Genetics, Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 502,869 shares of FLGT stock, worth $9.42 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

502,869

Previous 489,549 2.72%

Holding current value

$9.42 Million

Previous $9.6 Million 13.72%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$19.6 - $25.06 $261,072 - $333,799	13,320 Added 2.72%	502,869 $10.9 Million
Q2 2024 Aug 09, 2024	BUY	$19.09 - $22.57 $327,737 - $387,481	17,168 Added 3.63%	489,549 $9.6 Million
Q1 2024 May 13, 2024	BUY	$21.55 - $29.29 $207,332 - $281,799	9,621 Added 2.08%	472,381 $10.3 Million
Q4 2023 Feb 13, 2024	BUY	$23.64 - $30.27 $474,454 - $607,518	20,070 Added 4.53%	462,760 $13.4 Million
Q3 2023 Nov 13, 2023	BUY	$26.74 - $40.81 $807,093 - $1.23 Million	30,183 Added 7.32%	442,690 $11.8 Million
Q2 2023 Aug 11, 2023	BUY	$28.52 - $40.7 $223,682 - $319,210	7,843 Added 1.94%	412,507 $15.3 Million
Q1 2023 May 15, 2023	BUY	$29.39 - $36.27 $268,448 - $331,290	9,134 Added 2.31%	404,664 $12.6 Million
Q4 2022 Feb 13, 2023	SELL	$29.23 - $40.28 $18,999 - $26,182	-650 Reduced 0.16%	395,530 $11.8 Million
Q3 2022 Nov 14, 2022	BUY	$37.92 - $63.74 $501,378 - $842,770	13,222 Added 3.45%	396,180 $15.1 Million
Q2 2022 Aug 12, 2022	BUY	$47.98 - $62.75 $336,531 - $440,128	7,014 Added 1.87%	382,958 $20.9 Million
Q1 2022 May 13, 2022	BUY	$49.85 - $96.11 $86,390 - $166,558	1,733 Added 0.46%	375,944 $23.5 Million
Q4 2021 Feb 11, 2022	BUY	$77.3 - $105.0 $1.11 Million - $1.51 Million	14,369 Added 3.99%	374,211 $37.6 Million
Q3 2021 Nov 12, 2021	BUY	$74.87 - $110.87 $1.79 Million - $2.66 Million	23,963 Added 7.13%	359,842 $32.4 Million
Q2 2021 Aug 13, 2021	BUY	$66.8 - $100.45 $4.54 Million - $6.83 Million	67,971 Added 25.37%	335,879 $31 Million
Q1 2021 May 12, 2021	BUY	$59.3 - $183.85 $4.25 Million - $13.2 Million	71,596 Added 36.47%	267,908 $25.9 Million
Q4 2020 Feb 12, 2021	BUY	$31.01 - $52.1 $1.27 Million - $2.13 Million	40,933 Added 26.34%	196,312 $10.2 Million
Q3 2020 Nov 13, 2020	SELL	$15.89 - $50.51 $13,633 - $43,337	-858 Reduced 0.55%	155,379 $6.22 Million
Q2 2020 Aug 13, 2020	BUY	$8.89 - $18.28 $525,674 - $1.08 Million	59,131 Added 60.89%	156,237 $2.5 Million
Q1 2020 May 14, 2020	BUY	$6.75 - $19.75 $22,362 - $65,431	3,313 Added 3.53%	97,106 $1.04 Million
Q4 2019 Feb 13, 2020	BUY	$9.29 - $15.82 $585,455 - $996,976	63,020 Added 204.79%	93,793 $1.21 Million
Q3 2019 Nov 12, 2019	BUY	$5.96 - $12.81 $183,407 - $394,202	30,773 New	30,773 $319,000

Others Institutions Holding FLGT

# of Institutions

201

Shares Held

16.1M

Call Options Held

2.04M

Put Options Held

14K

View Full List

About Fulgent Genetics, Inc.

Ticker FLGT
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 30,265,800
Market Cap $567M
Description
Fulgent Genetics, Inc., together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally. The company offers genetic tests comprising Focus and Comprehensive oncology panels tests; Beacon carrier screening panels test for inherited conditions...

More about FLGT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.

Account

Geode Capital Management, LLC Fulgent Genetics, Inc. Transaction History